Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02320292
Title Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Mayo Clinic
Indications

follicular lymphoma

Therapies

Rituximab

Ibritumomab tiuxetan + Rituximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.